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Celiac disease can be de®ned as the classical manifes-
tation of gluten sensitivity, which primarily affects
the small intestine. Gluten sensitivity has also a skin
manifestation, i.e., dermatitis herpetiformis. Both
diseases have a strong genetic association with HLA
DQ on chromosome 6. In this study we tried to esti-
mate how much different clinical expressions of glu-
ten sensitivity are determined by genetic factors, and
hence how feasible they are for genetic mapping;
therefore, we studied all six monozygous twin pairs
found among 1292 prospectively collected patients of
dermatitis herpetiformis in Finland. Three of the six
twin pairs were concordant for dermatitis herpetifor-
mis and for simultaneous enteropathy, celiac disease.
Two other twin pairs were partially discordant, one
of each pair had dermatitis herpetiformis and celiac
disease, whereas the other had solely the gut mani-
festation of gluten sensitivity, i.e., celiac disease.
Only one pair was found to be discordant for gluten
sensitivity. All the pairs had typical risk alleles for
gluten sensitivity, i.e., either HLA DQ2 or DQ8.
These results demonstrate that the genetic compo-
nent in gluten sensitivity as broadly de®ned is very
strong (5/6 concordant). Genetically identical indivi-
duals can have clearly distinguished phenotypes,
either dermatitis herpetiformis or celiac disease, sug-
gesting that environmental factors determine the
exact phenotype of this multifactorial disease. These
®ndings are of importance in genetic linkage ana-
lyses, which focus to only certain phenotypic proper-
ties of a complex trait. Key words: genetic mapping/
gluten sensitivity/multifactorial disease. J Invest Dermatol
115:990±993, 2000
C
eliac disease (CD) is the classical manifestation of
gluten sensitivity. CD is characterized by intestinal
mucosal atrophy caused by dietary gluten (MaÈki and
Collin, 1997). Another manifestation of gluten
sensitivity is dermatitis herpetiformis (DH), in which
symptoms primarily occur on the skin as a blistering rash with
diagnostic cutaneous IgA deposits (van der Meer, 1969). Patients
with DH rarely have gastrointestinal symptoms, but all have jejunal
villous atrophy or at least immune activation typical of celiac
disease, including an increased number of g/d T cell receptor
bearing lymphocytes in the intestinal epithelium (Savilahti et al,
1992). The rash in DH disappears on a strict gluten-free diet (Fry
et al, 1973; Reunala et al, 1977) and relapses on gluten challenge
(Leonard et al, 1983); however, the exact pathomechanism of the
rash is still unknown.
CD has a clear genetic component: »10±15% of the ®rst-degree
relatives have the disease as compared with less than 1/300 in the
random population. The only established genetic susceptibility
factors for CD are HLA DQ2 (i.e., combination of the
DQA1*0501 and DQB1*02 alleles) and HLA DQ8 (i.e.,
combination of the DQA1*03 and DQB1*0302 alleles) on
chromosome 6. Essentially all patients have these HLA DQ risk
factors (Sollid and Thorsby, 1993; Polvi et al, 1998). The HLA loci,
however, explain only part of the entire genetic susceptibility to
CD. The other loci are not known at the moment, although some
promising non-HLA candidates have been suggested (Greco et al,
1998; Holopainen et al, 1999). Similarly to CD, 5±10% of the
patients with DH have ®rst-degree relatives affected by DH or CD
(Meyer and Zone, 1987; Reunala, 1996). DH also shares the same
strong HLA DQ associations with CD (Ahmed et al, 1993; Balas
et al, 1997; Spurkland et al, 1997), but it is not known whether
other genetic factors distinguish DH from CD.
Genetic linkage analyses of multifactorial diseases, of which
gluten sensitivity is an example, aim to identify novel susceptibility
loci. The genetic background of a single clinical trait, such as DH
or type I diabetes, may often be too heterogeneous for effective
analyses. An obvious alternative is to restrict the analysis to single
readily distinguishable clinical subgroups characteristic of the
disease entity. For this approach to be effective, the particular trait
on focus must be genetically determined. One way to test this is to
study the variation of the trait in monozygous twins. The
concordance of gluten sensitivity in monozygous twins has been
suggested to be even 60±80%, which is high for a multifactorial
disease. For example, the concordance in type I diabetes is only
< 40% (Cordell and Todd, 1995); however, the ®gures in CD and
DH are based on a collection of sporadic cases (Marks et al, 1971;
Walker-Smith, 1973; Penna et al, 1979; Jepsen and Ullman, 1980;
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Polanco et al, 1981; Greenberg et al, 1982; Lee et al, 1982; Khuffash
et al, 1984; Kosnai et al, 1985; Green et al, 1986; Salazar de Sousa
et al, 1987; Anstey et al, 1991; Strober, 1992; Holtmeier et al, 1997)
and there appears to be no systematic screening using modern
diagnostic criteria. In this study we describe an analysis of the
manifestation of gluten sensitivity in monozygous twins. DH
patients in Finland were systematically screened for monozygous
twin pairs and we particularly wanted to evaluate how much
genetic factors determine the skin, i.e., DH manifestation, and
intestinal, i.e., CD manifestation, of gluten sensitivity.
MATERIALS AND METHODS
Patients A total of 1292 patients with DH were collected at the
dermatologic departments of Finnish hospitals between 1969 and 1999.
The diagnosis was based on the presence of granular IgA deposits in the
skin. The occurrence of DH or CD in the families of the patients was asked
as described by Reunala (1996). The diagnosis of CD was based on the
demonstration of subtotal or partial villous atrophy in the small intestine
and histologic response on the gluten-free diet treatment (Collin et al,
1997). All twin pairs were re-examined in 1999 for adherence to gluten-
free diet, presence of the rash or gastrointestinal symptoms, and IgA
antibodies to gliadin and endomysium (Reunala et al, 1987).
Genetic analysis Blood samples were drawn from each monozygous
twin for genetic analyses. Eight microsatellite markers from different
chromosomes were used for identi®cation. These markers D1S1589,
D9S158, D10S1213, D14S617, D15S642, D16S403, D17S1293, and
D18S851, were typed using standard genotyping procedures. Brie¯y, 4 ml
of primers (10 mM) were mixed with 1 ml 10 3 buffer including 15 mM
MgCl2, 200 mM each of the nucleotides, 1 unit of AmpliTaq Gold (Perkin-
Elmer, Foster City, CA), 1.8 ml H2O, and 10±20 ng DNA. Ampli®cation
cycles were 95°C 30 s, 55°C 1 min, 72°C 1 min. The HLA alleles were
determined using the Lipa DRB1, DQB1, and DPB1 reverse dot blot kits
(Innogenetics, Dartford, U.K.) and the Dynal DQA1 SSP kit (Dynal AS,
Oslo, Norway). In addition, seven microsatellites located in the HLA area,
MOGc, D6S265, MIB, tumor necrosis factor-a and -b, G51152, and
D6S291 (Karell et al, 2000) were typed.
Statistics To estimate the probability that the assumed twins are
genuinely monozygotic rather than dizygotic ones, the following was
carried out: a nonmonozygotic sib pair has a prior probability of 0.25 to be
identical by descent in any fully informative locus. For eight unlinked loci
the probability is (0.25)8 = 0.000015. It is of note that the actual probability
is higher, as the loci cannot be assumed to be fully informative. The HLA
locus was not included in the calculation, as DH is strongly associated with
the HLA DR3 DQ2 and HLA DR4 DQ8 alleles. The casewise
concordance rate, Cc, was estimated as described by MacGregor (2000),
i.e., Cc = 2C/(2C + D), where C stands for the number of pairs concordant
and D for discordant.
RESULTS
Altogether, 1292 Finnish patients with DH could be identi®ed. Six
of them reported to have an apparently monozygous twin
(Table I). The monozygocity was tested by typing eight unlinked
microsatellite markers and the HLA markers. These marker loci
mapped to nine different chromosomes, so they could be regarded
as independent from each other. In each pair, the alleles were found
to be identical (data not shown), thus monozygocity could be
assumed. The frequency of monozygous twins in this material was
6/1292 = 0.005, which is equal to those reported in many
populations, i.e., approximately 0.004 (Vogel and Moltulsky,
1997).
In order to estimate the concordance rate for gluten sensitivity all
six twin pairs were re-examined in 1999. The presence of clinical
symptoms, IgA antibodies to gliadin and endomysium, and
adherence to a gluten-free diet was studied for those diagnosed as
having DH or CD. The discordant twin (6B, Table I) underwent a
second gastroscopy on a normal gluten containing diet and skin
immuno¯uorescence biopsy was taken in the same occasion.
Twin pairs 1, 4, and 5 were concordant for DH, i.e., they had
typical rash and granular IgA deposits on the skin (Table I). Twins
1 and 4 presented with subtotal or partial villous atrophy but had no
gastrointestinal symptoms or signs of malabsorption. Twin 5B had
the normal villus structure, although she had increased levels of IgA
anti-gliadin (0.40 EU per ml; normal < 0.20 EU per ml) and
reticulin antibodies (titre 1/100; normal < 1/5) whereas her twin
sister 5A presented gastrointestinal symptoms and had positive
serology and partial villus atrophy compatible with CD.
Twins 2 and 3 were DH±CD pairs, i.e., concordant for gluten
sensitivity, but their clinical outcome was different. Twin 2A had
DH and subtotal villous atrophy, whereas twin 2B had partial
villous atrophy, i.e., CD, but no rash and IgA deposits on the skin
at the time of diagnosis of CD. A 50% potassium iodine patch test
(Airola et al, 1997) was performed when twins 2A and 2B had been
on a gluten-free diet for 2 and 1 y, respectively. As expected, it was
positive for twin 2A (Fig 1), but in twin 2B it was clinically and
histologically negative and showed no IgA deposits. The response
to a gluten-free diet was good in both twins and twin 2A could stop
using dapsone after 1 y on the diet. Twin 3A had DH with IgA
deposits but no jejunal biopsy was performed, because of the
negative anti-gliadin and reticulin antibody tests. She was treated
with dapsone and on a gluten-free diet, and while on the diet she
was able to stop using dapsone. Her sister, twin 3B, had no history
of rash, but due to continuous diarrhoea and low hemoglobin a
jejunal biopsy was performed. This showed partial villous atrophy
after which she adhered to a gluten-free diet. After 2 mo on the diet
she was symptom free and no control jejunal biopsies were taken.
Ten years after the diagnosis of CD, she still adhered strictly to the
diet, had no gastrointestinal or cutaneous symptoms and the tests
for IgA gliadin and endomysium antibodies were negative.
Twin pair 6 was the only one discordant for gluten sensitivity
disorders. Twin 6A was found to have DH and partial villus
atrophy without gastrointestinal symptoms at the age of 38 and was
Table I. Clinical and laboratory ®ndings of six monozygous twin pairsa
Twin 1 Twin 2 Twin 3 Twin 4 Twin 5 Twin 6
A B A B A B A B A B A B
Gender/birth year F/1951 F/1965 F/1958 M/1970 F/1938 M/1958
Age at diagnosis DH/26 DH/27 DH/23 CD/25 DH/27 CD/31 DH/23 DH/24 DH/29 DH/54 DH/38 No disease
Age at onset 26 17 22 24 25 30 23 23 27 44 35 ±
of symptoms
Skin IgA depositsb pos pos pos neg pos nd pos pos pos pos pos neg
GI symptomsc neg neg neg pos neg pos neg neg pos neg pos neg
Jejunal biopsy PVA SVA SVA PVA nd PVA SVA SVA PVA normal PVA normald
Serologye nd pos pos pos neg nd pos pos pos pos pos neg
apos, present; neg, absent; nd, not done; SVA, subtotal villus atrophy; PVA, partial villus atrophy; normal, normal villous architecture.
bGranular IgA deposits in direct immuno¯uorescence when the patients were on a normal gluten-containing diet.
cGI, gastrointestinal symptoms such as loose stools or abdominal pain suggestive for CD.
dNumber of intraepithelial lymphocytes (a/b and g/d T cell receptor positives) also normal.
eIgA class anti-gliadin and/or reticulin/endomysium antibodies at the time of diagnosis.
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treated with a gluten-free diet. The rash was rapidly controlled by
the diet and the anti-gliadin and anti-endomysium antibody levels
fell to the normal range (< 0.20 EU per ml and < 1/8, respectively).
His twin brother 6B was on a normal gluten-containing diet, but
had no history of symptoms compatible for CD or DH. A jejunal
biopsy was performed twice, at the age of 38 and 41; the normal
villous structure was observed in both occasions. At the age of 41,
specimens were also taken for immunohistologic examination
(Savilahti et al 1992), but the numbers of the intraepithelial CD3+
(9 cells per mm) as well as a/b and g/d T cell receptor positive
lymphocytes (7 cells per mm and 0 cells per mm, respectively) and
DR-positive crypt cells were all within the normal range. Similarly,
the total IgA antibody level in the serum was within the normal
range, and the IgA anti-gliadin and endomysium antibody tests
taken on several occasions were negative. CD was, therefore,
excluded in twin 6B both by the repeated jejunal biopsies and
serologic tests, and DH by a negative biopsy for cutaneous IgA
deposits and the absence of rash. Consequently, ®ve of the six pairs
were concordant with respect to gluten sensitivity, giving the
casewise concordance rate of 0.91.
All the twins had the HLA DR and DQ alleles associated with DH
and CD (Table II). Pair 1 was homozygous for DR4 DQ8 and the
others were positive for DR3 DQ2. Pairs 2 and 4 were DR3 DQ2
homozygous and twin pairs 3 and 5 were homozygous for the
DQA1*0501 risk allele. Interestingly, twin pair 6, who was not
concordant for any gluten sensitivity disorder, was the only one, who
had nohomozygosity in anyHLArisk loci; otherwise, however, there
appeared to be no clear overall association between the HLA risk
alleles and clinical manifestation between the twin pairs.
DISCUSSION
This study describes a systematic analysis of gluten sensitivity in
monozygous twins. We screened twins among a large collection of
patients with DH and found six patients who were monozygous
twins. The monozygosity was con®rmed by genetic markers. Five
of the six twin pairs were concordant for a broad de®nition of
gluten sensitivity, i.e., DH or CD, but when more stringent criteria
were applied half of the pairs were found to have similar
manifestations. Only one pair was found to be discordant for any
manifestation of gluten sensitivity. This resulted in the casewise
concordance rate of 0.91, which is surprisingly high, because the
concordance rates in many complex diseases have been reported to
be clearly lower, usually well below 0.5. Of note is that the
concordance rate among siblings in a Finnish DH family study
(Reunala, 1996) was much lower. It should be noted that the
diagnostic criteria in most other twin studies of complex diseases
have been more stringent than in the present one. As discussed by
Strachan (2000) an inclusive, broader de®nition of cases often leads
to a higher concordance; our study, in which gluten sensitivity
included both DH and CD, supports this conclusion. Our result,
however, can be interpreted to indicate that, having almost 100%
concordance, the actual genetic complexity of gluten sensitivity
may not be as high as previously assumed.
The follow-up period for the present twins varied from 3 y up to
over 30 y. As the discordant pair had the shortest follow-up period,
it is still possible that they could even turn out to be concordant
later. As the presentation of both DH and CD is dependent on a
gluten-containing diet, it is impossible to estimate how many of the
CD patients would also develop DH, if they carry on with a gluten-
containing diet. The concordance rates for CD or DH cited in the
literature (Strober, 1992) are at the same level to that obtained in
the our study. Previously, two studies also reported (Jepsen and
Ullman, 1980; Kosnai et al, 1985) the occurrence of twins
discordant for DH, but concordant for CD manifestation; as in
our study, they used skin immuno¯uorescence to exclude DH.
The fact that the incidence of gluten sensitivity has shown
surprising ¯uctuations (e.g., in Sweden (Ascher, 1997) and that the
age of onset has increased in many countries (Visakorpi, 1997)
indicate that in addition to genetic factors, there are certainly also
environmental agents that are important. The amount of gluten
ingested is one factor, but others are possible as well. Interestingly,
Holtmeier et al (1997) showed that monozygotic twins concordant
for CD had developed different sets of T cell antigen receptors
repertoires, obviously due to different environmental triggers. This
result may provide one explanation for the variation in phenotypes
observed in our study. The number of genetic risk alleles carried by
each twin pair may also have an effect on the concordance, as the
only discordant pair in the our study had the heterozygous risk
alleles in both the HLA DQA1 and DQB1 loci, whereas those
concordant were risk allele homozygotes in both or at least one of
the DQ loci. This ®nding should be tested in independent studies,
as it emphasizes the primary role of DQ in the overall genetic
susceptibility to gluten sensitivity.
Although the number of pairs was not suf®ciently high for the
proper statistical analyses of variation, the present series is one of the
few, which was obtained by a systematic screening and was
examined using the modern diagnostic criteria. The collection was
not based on a population-based twin registry, which would be the
ideal choice. The fact that a prospective series of patients could be
Figure 1. Skin test in discordant twin pair. Patch-testing with 50%
potassium iodine in monozygous twins with dermatitis herpetiformis (left)
and CD (right). After 48 h redness and small blisters are seen in the test area
in the twin with dermatitis herpetiformis but not in the twin with CD.
Table II. HLA DRB1, DQA1, DQB1, and DPB1 alleles in
six monozygous twin pairs
Twin 1 Twin 2 Twin 3 Twin 4 Twin 5 Twin 6
DRB1 0401 0301 0301 0301 0301 0301
1201 1201 1301
DQA1 0301 0501 0501 0501 0501 0102
0501
DQB1 0302 02 02 02 02 02
0301 0301 0604
DPB1 0401 0101 0101 0101 0101 0101
0401 0401 0401 2001
DQa DQ8/8 DQ2/2 DQ2/x DQ2/2 DQ2/x DQ2/x
aDQ2 and DQ8 phenotype in each twin; x = non-DQ2, DQ8.
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studied, however, should minimize potential biases in the selection
of twin pairs and thus, in the concordance rate obtained. In
summary, this study clearly indicates that the manifestation of
gluten sensitivity can greatly vary in genetically identical indivi-
duals, some may have only the gut disorder, CD, the others
predominantly the skin affection, i.e., DH. This ®nding, that no
extra genes as such were needed for different phenotypes, is of
importance in genetic studies of gluten sensitivity.
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